Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer.

Kelley RK, Van Bebber SL, Phillips KA, Venook AP.

J Natl Compr Canc Netw. 2011 Jan;9(1):13-25. Review.

2.

Personalized Medicine: Genomics Trials in Oncology.

Hayes DF, Schott AF.

Trans Am Clin Climatol Assoc. 2015;126:133-43. Review.

3.

Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation.

Chung C, Christianson M.

J Oncol Pharm Pract. 2014 Feb;20(1):11-28. doi: 10.1177/1078155212474047. Epub 2013 Mar 14. Review.

PMID:
23493335
4.
5.

Optimizing the Clinical Utility of Biomarkers in Oncology: The NCCN Biomarkers Compendium.

Birkeland ML, McClure JS.

Arch Pathol Lab Med. 2015 May;139(5):608-11. doi: 10.5858/arpa.2014-0146-RA. Epub 2014 Oct 21.

PMID:
25333835
6.

Biomarkers for personalized oncology: recent advances and future challenges.

Kalia M.

Metabolism. 2015 Mar;64(3 Suppl 1):S16-21. doi: 10.1016/j.metabol.2014.10.027. Epub 2014 Oct 30. Review.

PMID:
25468140
7.

Biomarkers for personalized medicine in GI cancers.

Zhang SY, Zhang SQ, Nagaraju GP, El-Rayes BF.

Mol Aspects Med. 2015 Nov;45:14-27. doi: 10.1016/j.mam.2015.06.002. Epub 2015 Jun 6. Review.

PMID:
26054566
8.

Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic.

Prudkin L, Nuciforo P.

Cell Oncol (Dordr). 2015 Feb;38(1):39-48. doi: 10.1007/s13402-014-0192-6. Epub 2014 Sep 4. Review.

PMID:
25185990
9.

The role of K-RAS and B-RAF mutations as biomarkers in metastatic colorectal cancer.

Selcukbiricik F, Erdamar S, Ozkurt CU, Molinas Mandel N, Demirelli F, Ozguroglu M, Tural D, Buyukunal E, Serdengecti S.

J BUON. 2013 Jan-Mar;18(1):116-23.

PMID:
23613396
10.

Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.

De Mattia E, Cecchin E, Toffoli G.

Drug Resist Updat. 2015 May;20:39-70. doi: 10.1016/j.drup.2015.05.003. Epub 2015 May 22. Review.

PMID:
26027741
11.

Personalized treatment for patients with colorectal cancer: role of biomarkers.

Duffy MJ.

Biomark Med. 2015;9(4):337-47. doi: 10.2217/bmm.15.3. Review.

PMID:
25808438
12.

KRAS mutation screening in colorectal cancer: From paper to practice.

Fakih MM.

Clin Colorectal Cancer. 2010 Jan;9(1):22-30. doi: 10.3816/CCC.2010.n.003. Review.

PMID:
20100685
13.

The process of NCCN guidelines adaptation to the Middle East and North Africa region.

Jazieh AR, Azim HA, McClure J, Jahanzeb M.

J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S5-7.

PMID:
20697132
14.

Multigene Panel Testing in Oncology Practice: How Should We Respond?

Kurian AW, Ford JM.

JAMA Oncol. 2015 Jun;1(3):277-8. doi: 10.1001/jamaoncol.2015.28. No abstract available. Erratum in: JAMA Oncol. 2015 Jun;1(3):280.

PMID:
26181167
15.

Clinical implementation of KRAS testing in metastatic colorectal carcinoma: the pathologist's perspective.

Ross JS.

Arch Pathol Lab Med. 2012 Oct;136(10):1298-307. Epub 2012 Jan 24. Review.

PMID:
22272560
16.

Translating clinical research of Molecular Biology into a personalized, multidisciplinary approach of colorectal cancer patients.

Strambu V, Garofil D, Pop F, Radu P, Bratucu M, Popa F.

J Med Life. 2014 Mar 15;7(1):17-26. Epub 2014 Mar 25.

17.

Next-Generation Sequencing in Oncology in the Era of Precision Medicine.

Blumenthal GM, Mansfield E, Pazdur R.

JAMA Oncol. 2016 Jan;2(1):13-4. doi: 10.1001/jamaoncol.2015.4503. No abstract available.

PMID:
26540172
18.

Personalized medicine: CCO's vision, accomplishments and future plans.

Guo J, Kamel-Reid S, Rutherford M, Hart J, Melamed S, Pollett A.

Healthc Q. 2015;17 Spec No:41-3.

PMID:
25562133
19.

Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).

García-Alfonso P, Salazar R, García-Foncillas J, Musulén E, García-Carbonero R, Payá A, Pérez-Segura P, Ramón y Cajal S, Navarro S; Spanish Society of Medical Oncology (SEOM).; Spanish Society of Pathology (SEAP)..

Clin Transl Oncol. 2012 Oct;14(10):726-39. doi: 10.1007/s12094-012-0856-5. Epub 2012 Jul 27.

PMID:
22855150
20.

[Personalized medicine--the future is already here].

Abadi-Korek I, Shemer J.

Harefuah. 2011 May;150(5):451-2, 490. Hebrew.

PMID:
21678641

Supplemental Content

Support Center